They are exciting and biologically plausible, but randomized trials specifically designed to evaluate thromboembolic outcomes would be needed before GLP-1s could be formally recommended primarily for VTE or PE prevention, Yi said.
Introduction If your scale has not moved in weeks despite staying on your GLP1 medication, you are not alone
For example, initiating therapy soon after diagnosis could improve glycemic control before significant beta-cell decline occurs
[9] To get Wegovy approved, you must meet all of: A 6-month weight-management program first documented behavioral modification, reduced-calorie diet, and increased physical activity with continuing follow-up (this is the real hurdle, not another drug) BMI 30 , or 27 with a weight-related condition (hypertension, type 2 diabetes, or dyslipidemia) Age 18+ (ages 1217 require the injection plus the comprehensive program) No drug step therapy: CVS Caremark's standard Wegovy policy does not require trying and failing another weight-loss drug first (some individual employer plans add it check yours) Wegovy also has separate coverage pathways for cardiovascular risk reduction (established heart disease + BMI 27, if you don't have type 2 diabetes) and MASH liver disease
Arrive hydrated and eat a light meal unless your provider gives different instructions
Hair that appears gray may also be from the mix of white and pigmented strands on the head, too